DURANDO, ANDREA
DURANDO, ANDREA
170011 - UNIVERSITA' DEGLI STUDI DI GENOVA
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial
2016-01-01 Del Mastro, L; Levaggi, A; Michelotti, A; Cavazzini, G; Adami, Francesca; Scotto, T; Piras, M; Danese, S; Garrone, O; Durando, A; Accortanzo, V; Bighin, C; Miglietta, L; Pastorino, S; Pronzato, P; Castiglione, F; Landucci, E; Conte, Pierfranco; Bruzzi, P
Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study
2001-01-01 Rosso, R.; Del Mastro, L.; Durando, A.; Garrone, O.; Cherubini, R.; Scotto, T.; Genta, F.; Occelli, M.; Bellino, R.; Bighin, C.; Catzeddu, T.; Stevani, I.; Baldini, A.; Lambiase, A.; Venturini, M.
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies
2017-01-01 Lambertini, M; Ceppi, M; Cognetti, F; Cavazzini, G; De Laurentiis, M; De Placido, S; Michelotti, A; Bisagni, G; Durando, A; Valle, E; Scotto, T; De Censi, A; Turletti, A; Benasso, M; Barni, S; Montemurro, F; Puglisi, F; Levaggi, A ); Giraudi, S; Bighin, C; Bruzzi, P; Del Mastro, L
O-4 Ovarian suppression (OS) and tamoxifen (TAM) as an alternative to chemotherapy in early breast cancer. Long-term results of the GROCTA02 trial
2007-01-01 Boccardo, Francesco; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Mesiti, D.; Durando, Andrea; Bolognesi, Alessandra; Farris, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial | 1-gen-2016 | Del Mastro, L; Levaggi, A; Michelotti, A; Cavazzini, G; Adami, Francesca; Scotto, T; Piras, M; Danese, S; Garrone, O; Durando, A; Accortanzo, V; Bighin, C; Miglietta, L; Pastorino, S; Pronzato, P; Castiglione, F; Landucci, E; Conte, Pierfranco; Bruzzi, P | |
| Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study | 1-gen-2001 | Rosso, R.; Del Mastro, L.; Durando, A.; Garrone, O.; Cherubini, R.; Scotto, T.; Genta, F.; Occelli, M.; Bellino, R.; Bighin, C.; Catzeddu, T.; Stevani, I.; Baldini, A.; Lambiase, A.; Venturini, M. | |
| Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies | 1-gen-2017 | Lambertini, M; Ceppi, M; Cognetti, F; Cavazzini, G; De Laurentiis, M; De Placido, S; Michelotti, A; Bisagni, G; Durando, A; Valle, E; Scotto, T; De Censi, A; Turletti, A; Benasso, M; Barni, S; Montemurro, F; Puglisi, F; Levaggi, A ); Giraudi, S; Bighin, C; Bruzzi, P; Del Mastro, L | |
| O-4 Ovarian suppression (OS) and tamoxifen (TAM) as an alternative to chemotherapy in early breast cancer. Long-term results of the GROCTA02 trial | 1-gen-2007 | Boccardo, Francesco; Rubagotti, Alessandra; Guglielmini, PAMELA FRANCESCA; Mesiti, D.; Durando, Andrea; Bolognesi, Alessandra; Farris, A. |